Obesity and being overweight are serious conditions associated with type 2 diabetes mellitus (T2DM)
for others, it may contribute to rebound preferences for sugars and refined carbohydrates if they delay eating until they are overly hungry
We found that these altered patterns are increasingly common, yet there is currently no national or international guidance in the UK addressing this emerging issue. The authors note, however, that Australian guidancewhich references the use of GLP-1ssuggests continuing treatment, fasting from midnight, scheduling morning scans and ensuring good glucose control
Symptoms of GLP-1 induced gastroparesis often match other common GI disorders
GLP-1 inesi brakldnda itah ve tokluk mekanizmalar yeniden deiebilir
Practice Takeaway This large-scale pharmacovigilance study's findings indicate that the combination of metformin and GLP-1 RAs demonstrates a superior real-world safety profile compared to either agent used alone, thereby suggesting metformin as a safety-enhancing anchor in the GLP-1 RA-treated patient care journey
